Innovation

Australian medical technology company Harrison.ai has launched a radiology-specific generative AI model – and it’s already scoring higher than OpenAI and Gemini.

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end up being an effective treatment for Alzheimer’s, heart conditions, depression, and many other conditions.

The Bolt founder claimed a group of investors had signed off on the company’s chaotic $450 million raise, but some said they hadn’t. Now, BlackRock and other investors have moved to stall the round.

Blackstone confirms to Forbes Australia it sealed a deal today to acquire Australian unicorn AirTrunk. The Canada Pension Plan Investment Board also participated in the deal.

Interest in artificial intelligence continues to surge, as Google searches over the past 12 months are at 92% of their all-time peak, but recent research suggests AI’s success could be its downfall.

Australia’s domestic aviation landscape may be poised for a shake-up with Melbourne-based carrier Koala Airlines aiming to fill the void following the collapse of budget airlines Rex and Bonza.

What stage are the 25 most disruptive technologies at, and when will they become reality? Gartner’s annual Emerging Technology Hype Cycle reveals what is on the frontier, and what has reached the peak of inflated expectations.

While 74% of companies are seeing positive returns, Vice President of Global Generative AI Go-To-Market for Google Cloud Oliver Parker says C-level buy-in boosts them.

Coaching programs that rely on artificial intelligence are cheap, accessible and increasingly popular. But privacy questions and skepticism over the quality of non-human answers could slow adoption.

Ten-year-old startup Andela, valued at $1.5 billion, expects to grow its tech contractor marketplace by 15% this year.